Interferon reduces the risk of hepatocellular carcinoma in hepatitis C virus-related chronic hepatitis/liver cirrhosis.

Masuzaki R, Yoshida H, Omata M
Oncology. 2010 78 Suppl 1: 17-23

PMID: 20616579 · DOI:10.1159/000315225

MeSH Terms (12)

Antiviral Agents Carcinoma, Hepatocellular Chronic Disease Clinical Trials as Topic Hepacivirus Hepatitis C, Chronic Humans Interferons Liver Cirrhosis Liver Neoplasms Prognosis Risk Factors

Connections (1)

This publication is referenced by other Labnodes entities: